產(chǎn)品詳情
簡單介紹：
Anti-C17orf66抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C17orf66抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C17orf66
Cat. Number:
Anti-C17orf66抗體KL-9644R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C17orf66 is a 570 amino acid protein that is encoded by a gene mapping to human chromosome 17. Chromosome 17 makes up over 2.5% of the human genome with about 81 million bases encoding over 1,200 genes. Two keyAnti-C17orf66抗體 tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. Like p53, BRCA1 is directly involved in DNA repair, specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, colon, prostate gland and fallopian tubes. Chromosome 17 is also linked to neurofibromatosis, a condition characterized by neural and epidermal lesions, and dysregulated Schwann cell growth. Alexander disease, Birt-Hogg-Dube syndrome and Canavan disease are also associated with chromosome 17.
Also known as:
chromosome 17 open Anti-C17orf66抗體reading frame 66; FLJ32830; hypothetical protein LOC256957; Uncharacterized protein C17orf66;
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C17orf66.
●
Predicted Molecular Anti-C17orf66抗體Weight: 66kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-C17orf66抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl311Mu02 阿黑皮素原(POMC)多克隆抗體 Polyclonal Antibody to Proopiomelanocortin (POMC)
kl312Mu02 分泌性白細胞蛋白酶抑制因子(SLPI)多克隆抗體 Polyclonal Antibody to Secretory Leukocyte Peptidase Inhibitor (SLPI)
kl313Mu02 整合素α1(ITGα1)多克隆抗體 Polyclonal Antibody to Integrin Alpha 1 (ITGa1)
kl315Mu01 整合素α4(ITGα4)多克隆抗體 Polyclonal Antibody to Integrin Alpha 4 (ITGa4)
kl315Mu02 整合素α4(ITGα4)多克隆抗體 Polyclonal Antibody to Integrin Alpha 4 (ITGa4)
kl316Mu02 前膠原C端蛋白酶增強子1(PCPE1)多克隆抗體 Polyclonal Antibody to Procollagen C Proteinase Enhancer 1 (PCPE1)
kl317Mu02 穿孔素1(PRF1)多克隆抗體 Polyclonal Antibody to Perforin 1 (PRF1)
kl320Mu02 胸腺基質(zhì)**細胞生成素(TSLP)多克隆抗體 Polyclonal Antibody to Thymic Stromal Lymphopoietin (TSLP)
kl324Hu01 鈣調(diào)結(jié)合蛋白(CALD)多克隆抗體 Polyclonal Antibody to Caldesmon (CALD)
kl324Ra01 鈣調(diào)結(jié)合蛋白(CALD)多克隆抗體 Polyclonal Antibody to Caldesmon (CALD)
kl327Mu02 生長關(guān)聯(lián)蛋白43(GAP43)多克隆抗體 Polyclonal Antibody to Growth Associated Protein 43 (GAP43)
kl329Mu02 微管關(guān)聯(lián)蛋白2(MAP2)多克隆抗體 Polyclonal Antibody to Microtubule Associated Protein 2 (MAP2)
kl331Mu02 套膜蛋白(iNV)多克隆抗體 Polyclonal Antibody to Involucrin (iNV)
kl332Mu01 鳥氨酸脫羧酶(ODC)多克隆抗體 Polyclonal Antibody to Ornithine Decarboxylase (ODC)
kl332Mu02 鳥氨酸脫羧酶(ODC)多克隆抗體 Polyclonal Antibody to Ornithine Decarboxylase (ODC)
kl332Ra01 鳥氨酸脫羧酶(ODC)多克隆抗體 Polyclonal Antibody to Ornithine Decarboxylase (ODC)
kl333Ra01 粘著斑激酶(FAK)多克隆抗體 Polyclonal Antibody to Focal Adhesion Kinase (FAK)
kl334Hu01 β-1,3-葡糖醛酸基移酶1(β3GAT1)多克隆抗體 Polyclonal Antibody to Beta-1,3-Glucuronyltransferase 1 (b3GAT1)
kl336Mu02 保護素(CD59)多克隆抗體 Polyclonal Antibody to Protectin (CD59)
kl337Mu02 彈性蛋白(ELN)多克隆抗體 Polyclonal Antibody to Elastin (ELN)
